HARRIS ERIK (EVP & Chief Commercial Officer) received a stock award from ULTRAGENYX PHARMACEUTICAL INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/20/2026ACC: 0001193125-26-164267
Officer· EVP & Chief Commercial Officer
Since Jun 2019
+78.86K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
78.86K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+28.89K
Price / share
—
Trade value
—
% of position
32.3%
4/16/2026
89.52K→118.41K
Total
Net shares
+28.89K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2026 | A · Award | +28.89K | — | — | 32.3% | 89.52K | 118.41K |
| Total | +28.89K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
49.96K shares
Shares
+49.96K
Strike price
24.52
Held after
49.96K
Exercisable
—
4/16/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock49.96K shares | 4/16/2026 | A · Award | +49.96K | 24.52 | — | 49.96K |